COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 163: Articles 1621-1630  | Next

Virtual rehabilitation for individuals with Long COVID: a randomized controlled trial.
Janaudis-Ferreira, T., Beauchamp, M. K., Rizk, A., Tansey, C. M., Sedeno, M., Barreto, L., Bourbeau, J., Ross, B. A., Benedetti, A., Li, P. Z., Agarwal, K., Zucco, R., Lopez, J., Crowley, E., Cloutier, J.
10.1101/2024.11.24.24317856 — Posted: 2024-11-26
A Cross-Sectional Survey of Knowledge, Attitudes and Practices (KAP) towards COVID-19 in working professionals of Islamabad during lockdown
Nisar, N., Badar, N., Safdar, I., Haider, M., Yaqoob, A.
10.1101/2024.11.24.24317870 — Posted: 2024-11-26
Association between COVID-19 Disease Severity and T Cell Receptor Repertoire
Chen, X., Su, Y., Dai, C., Goldman, J. D., Heath, J. R., Liu, S., Sun, W.
10.1101/2024.11.26.625333 — Posted: 2024-11-26
Diverse patterns of intra-host genetic diversity in chronically infected SARS-CoV-2 patients
Rutsinsky, N., Ben Zvi, A., Fabian, I., Segev, S. T., Jacobi, B., Harari, S., Meijers, S., Paran, Y., Stern, A.
10.1101/2024.11.23.624482 — Posted: 2024-11-25
Naturally occurring N-terminal mutations in SARS-CoV-2 nsp1 impact innate immune modulation but do not affect virus virulence
Rani, R., Nooruzzaman, M., Caserta, L. C., Diel, D.
10.1101/2024.11.23.624996 — Posted: 2024-11-25
Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine
Hernandez, G., Osinski, A., Majumdar, A., Eitson, J. L., Antczak, M., Pawlowski, K., Niederstrasser, H., Servage, K. A., Posner, B., Schoggins, J. W., Ready, J. A., Tagliabracci, V. S.
10.1101/2024.11.22.624893 — Posted: 2024-11-25
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Wang, K., Nie, Y., Maguire, C., Syphurs, C., Sheen, H., Karoly, M., Lapp, L., Gygi, J. P., Jayavelu, N. D., Patel, R. K., Hoch, A., IMPACC Network, , Corry, D., Kheradmand, F., McComsey, G. A., Fernandez-Sesma, A., Simon, V., Metcalf, J. P., Agudelo Higuita, N. I., Messer, W. B., David, M. M., Nadeau, K. C., Kraft, M., Bime, C., Schaenman, J., Erle, D., Calfee, C. S., Atkinson, M. A., Brackenridge, S. C., Hafler, D. A., Shaw, A. C., Rahman, A., Hough, C. L., Geng, L. N., Ozonoff, A., Haddad, E. K., Reed, E. F., Bakel, H. v., Kim-Schulze, S. H., Krammer, F., Wilson, M., Eckalbar, W., Bosinger, S., Langelier, C. R., Selaky, R., Montgomery, R. R., Maecker, H., Krumholz, H., Melamed, E., Steen, H., Pulendran, B., Augustine, A. D., Cairns, C. B., Rouphael, N., Becker, P. M., Fourati, S., Shannon, C. P., Smolen, K. K., Peters, B., Kleinstein, S. H., Levy, O., Altman, M. C., Iwasaki, A., Diray-Arce, J., Ehrlich, L. I. R., Guan, L.
10.1101/2024.11.22.624784 — Posted: 2024-11-25
Contributions to the force of infection of SARS-CoV-2 in Dutch long-term care facilities
de Wit, M. M., van Zelst, M., Boere, T. M., van Gaalen, R. D., de Jong, M. C. M., van Hoek, A. J., ten Bosch, Q.
10.1101/2024.11.19.24316339 — Posted: 2024-11-25
Elevated Blood Glucose in COVID-19 Patients: An explorative Study
Bisher, m. M., Thamer, A. A., Shahata, S. H., Atia, A. E.
10.1101/2024.11.15.24317345 — Posted: 2024-11-25
Estimates of SARS-CoV-2 infections and population immunity after the COVID-19 pandemic in Austria: Analysis of national wastewater data
Riedmann, U., Chalupka, A., Richter, L., Sprenger, M., Rauch, W., Schenk, H., Krause, R., Willeit, P., Oberacher, H., Hoeg, T. B., Ioannidis, J., Pilz, S.
10.1101/2024.11.20.24317646 — Posted: 2024-11-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).